Zacks Investment Research on MSN2d
Mirum's Heavy Dependence on Livmarli for Revenues Remains a Woe
Mirum Pharmaceuticals’ MIRM lead product, Livmarli (maralixibat), an orally administered ileal bile acid transporter (“IBAT”) ...
Inflammation and Scarring of the Bile Ducts: Causes, Diagnosis, and Treatments
Bile duct inflammation and scarring, known as cholangiopathies, can disrupt bile flow, leading to liver damage and ...
Biotech Alert: Searches spiking for these stocks today
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...